Alivion AG is using cutting-edge nanotechnology to extract and quantify one molecule out of a cloud of over 800 molecules in breath. The results are associated with the body’s metabolism allowing patients and health care professionals to evaluate the health status related to a specific biomarker. This will permit to replace blood tests having long been the gold standard for medical diagnostics.
With the financial boost of CHF 3.8 million by Innosuisse, the ongoing development of Alivion’s breath analysis platform and its testing can be accelerated. Patient testing is being conducted in collaboration with University Hospital Zurich and other partners.
Handheld device to detect Methanol
One of Alivion’s remarkable achievements is to create a platform of handheld gas molecule detectors providing the same accuracy of an analytical laboratory. Its first application is detecting methanol in spirits and drinks. In serious cases, methanol poisoning can lead to blindness or even death. It is usually triggered by contaminated alcoholic beverages that have been illegally mixed with methanol.